
New data for dupilumab presented at the 25th European Academy of Dermatology and Venereology Congress.

New data for dupilumab presented at the 25th European Academy of Dermatology and Venereology Congress.

Gastrointestinal-related adverse drug reactions common in unplanned hospitalizations.

Gilenya (fingolimod) can slow disability progression in patients with relapsing remitting multiple sclerosis.

AbbVie’s experimental compound treats moderate-to-severe chronic plaque psoriasis.

More than 600 lots of products recalled by Wells Pharmacy Network.

The American Academy of Pediatrics urges cessation of codeine use in children due to severe risks.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

CMS releases Medicare premium and cost data for 2017.

Study finds that recombinant human lubricin can offer symptom relief for patients with dry eye disease.

Allergan acquires Akarna Therapeutics, and has plans to acquire Tobira Therapeutics.

Top news of the day from across the healthcare landscape.

Individuals involved with the criminal justice system were more likely to receive mental health or substance use disorder treatment.

Illaris has been approved to treat 3 types of periodic fever syndromes.

In-depth look at clinically appropriate drug use and cost-saving opportunities in Medicaid programs.

Only 12.8% of all experimental diabetes drugs transition to phase 3 trials.

Top news of the day from across the health care landscape.

Amgen’s biosimilar Amjevita approved for variety of anti-inflammatory diseases, however, ongoing litigation may prevent it from hitting the market.

A majority of employers believe private companies could lower costs more efficiently than federal laws.

Top news of the day from across the healthcare landscape.

Amgen’s Amjevita, a biosimilar to Humira, approved for variety of anti-inflammatory diseases.

Allergan will expand their non-alcoholic steatohepatitis pipeline with the acquisition of Tobira therapeutics.

The 2016 Naloxone App Competition will create an application to link carriers of naloxone with those experiencing an opioid overdose.

Affordable Care Act premiums were as much as 35% lower than employer premiums.

Fetuses born to mothers with diabetes are more likely to have hypoglycemia, abnormal size, and malformation.

Top news of the day from across the healthcare landscape.

Abaloparatide can prevent bone fractures in postmenopausal women with osteoporosis.

Fast-acting Conus geographus venom insulin may lead to fast-acting insulins.

Top news of the day from across the healthcare landscape.

Popular attractions of Washington, DC that may interest specialty pharmacists.